SCHEMBL5064894

SCHEMBL5064894

C[C@H](NC(=O)O)c1ccc(C(O)Cc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MMP9 P14780 1/20 0.51
MMP8 P22894 1/20 0.51
MMP14 P50281 1/20 0.51
ALOX5 P09917 1/20 0.49
PTGDR2 Q9Y5Y4 1/20 0.48
EPHX2 P34913 2/20 0.48
SIGMAR1 Q99720 1/20 0.47
PSMB1 P20618 2/20 0.47
PSMB5 P28074 2/20 0.47
PSMB2 P49721 2/20 0.47
HPGD P15428 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL247742 0.80 HSD17B10 (0.63) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL249524 0.80 HSD17B10 (0.63) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL2672977 0.80 HSD17B10 (0.63) ALDH1A1KDM4EMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL4459970 0.79 HSD17B10 (0.61) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL9718520 0.79 HSD17B10 (0.61) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL17571990 0.78 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AMAPTHPGD
Alcohol SCHEMBL28032632 0.78 MEN1 (0.64) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL4259467 0.77 ADRB2 (0.54) ALDH1A1KDM4EMEN1KMT2AMAPT
Chloromethane SCHEMBL29855624 0.77 HSD17B10 (0.59) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13232184 0.77 TRPA1 (0.50) KDM4EMEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080305081-A1 Novel aminopyrimidine derivatives as PLK1 inhibitors BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305081-A1 Novel aminopyrimidine derivatives as PLK1 inhibitors PLK1, AURKA, CDK1 ALDH1A1 3451/4885KDM4E 1233/4885MEN1 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.